Press Releases

Date	Title	Company
09-Jul-2025	DEXIS Announces Final Countdown To First-Ever Scanner Sweepstakes	ACCESS Newswire
09-Jul-2025	Mann Eye Institute Introduces Groundbreaking Treatment for Dry AMD Patients	ACCESS Newswire
09-Jul-2025	Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement	ACCESS Newswire
09-Jul-2025	Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs	ACCESS Newswire
09-Jul-2025	Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives	ACCESS Newswire
09-Jul-2025	Ahead of World IVF Day, HRC Fertility Launches Innovative Clinical Trial with Gameto for More Approachable IVF	ACCESS Newswire
09-Jul-2025	Global Esoteric Testing Market Valuation and Growth Forecast to 2035	MBI
09-Jul-2025	Buy Semaglutide Online - Finding Best Place to Get Semaglutide for Weight Loss	ACCESS Newswire
09-Jul-2025	AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats	ACCESS Newswire
09-Jul-2025	iZafe Group Signs Agreement with AddSecure Smart Care Oy to launch Dosell in Finland	ACCESS Newswire
09-Jul-2025	Faron Announces Acceptance of Two Studies Involving Bexmarilimab, One of Them as an Oral Presentation, at the 19th International Congress of Immunology (IUIS) 2025	ACCESS Newswire
09-Jul-2025	Dr. Anosh Ahmed, Proud Republican Leader, Donates to Texas Flood Victims and Launches Relief Initiative	ACCESS Newswire
08-Jul-2025	BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology	ACCESS Newswire
08-Jul-2025	PrimeVigilance Enhances Efficiency and Patient Safety with Oracle Argus Platform	PrimeVigilance
08-Jul-2025	Modus Therapeutics completes enrollment in Part 1 of the Phase IIa sevuparin study in chronic kidney disease with anemia	Modus Therapeutics
08-Jul-2025	Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers	Eleva
08-Jul-2025	SMC recommends Eladynos®▼ (abaloparatide) for treating osteoporosis in postmenopausal women	Theramex
08-Jul-2025	Clinician-Powered AI Solutions Set a New Standard: Black Book Survey Reveals Six Vendors Earning Near-Perfect User Scores	ACCESS Newswire
08-Jul-2025	U.S. Surgical Retractors Market Key Players, Share and Forecast Outlook	Market Business Insights
08-Jul-2025	DNA Sequencing Market Size, Development, Key Opportunity, Application & Forecast by 2035	Market Business Insights